NEWS
January 26, 2012
Celgene to acquire Avila Therapeutics
Celgene Corp said on Thursday that it would acquire Avila Therapeutics Inc, a privately held biotechnology company, for $350 million in cash...
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|